Abstract

Dietary non-digestible carbohydrates are perceived to improve health via gut microbiota-dependent generation of products such as short-chain fatty acids (SCFA). In addition, SCFA are also precursors for lipid and cholesterol synthesis potentially resulting in unwanted effects on lipid metabolism. Inulin is a widely used model prebiotic dietary fiber. Inconsistent reports on the effects of inulin on cholesterol homeostasis have emerged in humans and preclinical models. To clarify this issue, the present study aimed to provide an in-depth characterization of the effects of short-chain (sc)- and long-chain (lc)- inulin on cholesterol synthesis, absorption and elimination in mice. Feeding wildtype C57BL/6J mice diets supplemented with 10% (w/w) of either sc- or lc-inulin for two weeks resulted in approximately 2.5-fold higher fecal SCFA levels (P < 0.01) compared with controls, but had no significant effects on plasma and liver lipids. Subtle shifts in fecal and plasma bile acid species were detected with beta-muricholic acid increasing significantly in plasma of the inulin fed groups (1.7-fold, P < 0.05). However, neither sc-inulin nor lc-inulin affected intestinal cholesterol absorption, mass fecal cholesterol excretion or trans-intestinal cholesterol excretion (TICE). Combined, our data demonstrate that sc- and lc-inulin have no adverse effects on cholesterol metabolism in mice despite increased generation of SCFA.

Highlights

  • Inulin is a soluble non-digestible carbohydrate studied for its health benefits such as improved bowel movements, lowering blood glucose levels and potential lipid modulating effects[1,2,3,4]

  • Considerable shifts were observed in terms of the ratio (Ac:Pr:Bu:Su) of short-chain fatty acids (SCFA) generated in sc-inulin (51:29:15:6) and lc-inulin (50:26:9:15) fed groups compared to mice fed control diet (61:25:10:4)

  • In the present study we aimed to investigate the effects of inulin on cholesterol homeostasis

Read more

Summary

Introduction

Inulin is a soluble non-digestible carbohydrate studied for its health benefits such as improved bowel movements, lowering blood glucose levels and potential lipid modulating effects[1,2,3,4]. Inulin undergoes fermentation by the microbiota in different parts of the intestine resulting in the production of short-chain fatty acids (SCFA)[9]. Thereby, inulin might exert adverse effects on metabolism by increasing plasma cholesterol levels and the risk for atherosclerotic cardiovascular disease. In the present study we aimed to elucidate in detail the effects of inulin on cholesterol absorption and elimination. Despite a substantially increased intestinal production of SCFA, inulin has no adverse effects on de novo cholesterol synthesis, intestinal cholesterol absorption or cholesterol elimination pathways. Significant differences are indicated as *P < 0.05; **P < 0.01

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call